欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HR/H/0129/002
药品名称Naxil forte 600 mg effervescent tablets
活性成分
    • acetylcysteine 600.0 mg
剂型Effervescent tablet
上市许可持有人BELUPO lijekovi i kozmetika d.d. Ulica Danica 5 48000 Koprivnica, Croatia
参考成员国 - 产品名称Croatia (HR)
Naxil forte 600 mg šumeće tablete
互认成员国 - 产品名称
    • Slovenia (SI)
许可日期2018/12/12
最近更新日期2023/10/13
药物ATC编码
    • R05CB01 acetylcysteine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase